Logo image of VRAP.PA

VRANKEN - POMMERY MONOPOLE (VRAP.PA) Stock Fundamental Analysis

EPA:VRAP - Euronext Paris - Matif - FR0000062796 - Common Stock - Currency: EUR

12.35  +0.05 (+0.41%)

Fundamental Rating

3

Overall VRAP gets a fundamental rating of 3 out of 10. We evaluated VRAP against 24 industry peers in the Beverages industry. While VRAP is still in line with the averages on profitability rating, there are concerns on its financial health. VRAP is valued expensive and it does not seem to be growing.


Dividend Valuation Growth Profitability Health

4

1. Profitability

1.1 Basic Checks

In the past year VRAP was profitable.
VRAP had a positive operating cash flow in the past year.
Each year in the past 5 years VRAP has been profitable.
VRAP had a positive operating cash flow in each of the past 5 years.
VRAP.PA Yearly Net Income VS EBIT VS OCF VS FCFVRAP.PA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20M 40M 60M

1.2 Ratios

VRAP's Return On Assets of 0.07% is on the low side compared to the rest of the industry. VRAP is outperformed by 86.96% of its industry peers.
With a Return On Equity value of 0.23%, VRAP is not doing good in the industry: 91.30% of the companies in the same industry are doing better.
With a Return On Invested Capital value of 2.04%, VRAP is not doing good in the industry: 95.65% of the companies in the same industry are doing better.
Measured over the past 3 years, the Average Return On Invested Capital for VRAP is significantly below the industry average of 7.90%.
Industry RankSector Rank
ROA 0.07%
ROE 0.23%
ROIC 2.04%
ROA(3y)0.44%
ROA(5y)0.39%
ROE(3y)1.41%
ROE(5y)1.26%
ROIC(3y)2.15%
ROIC(5y)1.97%
VRAP.PA Yearly ROA, ROE, ROICVRAP.PA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0.5 1 1.5 2 2.5

1.3 Margins

VRAP has a Profit Margin of 0.30%. This is amonst the worse of the industry: VRAP underperforms 86.96% of its industry peers.
In the last couple of years the Profit Margin of VRAP has grown nicely.
VRAP has a Operating Margin of 11.37%. This is in the lower half of the industry: VRAP underperforms 69.57% of its industry peers.
VRAP's Operating Margin has improved in the last couple of years.
VRAP's Gross Margin of 50.74% is in line compared to the rest of the industry. VRAP outperforms 47.83% of its industry peers.
In the last couple of years the Gross Margin of VRAP has remained more or less at the same level.
Industry RankSector Rank
OM 11.37%
PM (TTM) 0.3%
GM 50.74%
OM growth 3Y6.3%
OM growth 5Y8.09%
PM growth 3Y-50.55%
PM growth 5Y61.17%
GM growth 3Y3.29%
GM growth 5Y-0.37%
VRAP.PA Yearly Profit, Operating, Gross MarginsVRAP.PA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10 20 30 40 50

2

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), VRAP is destroying value.
Compared to 1 year ago, VRAP has about the same amount of shares outstanding.
VRAP has about the same amout of shares outstanding than it did 5 years ago.
Compared to 1 year ago, VRAP has a worse debt to assets ratio.
VRAP.PA Yearly Shares OutstandingVRAP.PA Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2M 4M 6M 8M
VRAP.PA Yearly Total Debt VS Total AssetsVRAP.PA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M 1B

2.2 Solvency

Based on the Altman-Z score of 0.85, we must say that VRAP is in the distress zone and has some risk of bankruptcy.
With a Altman-Z score value of 0.85, VRAP is not doing good in the industry: 91.30% of the companies in the same industry are doing better.
VRAP has a Debt/Equity ratio of 1.50. This is a high value indicating a heavy dependency on external financing.
Looking at the Debt to Equity ratio, with a value of 1.50, VRAP is doing worse than 69.57% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 1.5
Debt/FCF N/A
Altman-Z 0.85
ROIC/WACC0.45
WACC4.58%
VRAP.PA Yearly LT Debt VS Equity VS FCFVRAP.PA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M 400M 600M

2.3 Liquidity

VRAP has a Current Ratio of 2.02. This indicates that VRAP is financially healthy and has no problem in meeting its short term obligations.
The Current ratio of VRAP (2.02) is better than 78.26% of its industry peers.
VRAP has a Quick Ratio of 2.02. This is a bad value and indicates that VRAP is not financially healthy enough and could expect problems in meeting its short term obligations.
VRAP has a worse Quick ratio (0.27) than 91.30% of its industry peers.
Industry RankSector Rank
Current Ratio 2.02
Quick Ratio 0.27
VRAP.PA Yearly Current Assets VS Current LiabilitesVRAP.PA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M

3

3. Growth

3.1 Past

The earnings per share for VRAP have decreased strongly by -85.12% in the last year.
VRAP shows a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 64.31% yearly.
Looking at the last year, VRAP shows a very negative growth in Revenue. The Revenue has decreased by -10.16% in the last year.
The Revenue has been growing slightly by 2.05% on average over the past years.
EPS 1Y (TTM)-85.12%
EPS 3Y-50.41%
EPS 5Y64.31%
EPS Q2Q%-65.69%
Revenue 1Y (TTM)-10.16%
Revenue growth 3Y0.3%
Revenue growth 5Y2.05%
Sales Q2Q%-11.88%

3.2 Future

VRAP is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 18.12% yearly.
Based on estimates for the next years, VRAP will show a decrease in Revenue. The Revenue will decrease by -0.71% on average per year.
EPS Next Y84.26%
EPS Next 2Y60.73%
EPS Next 3Y18.12%
EPS Next 5YN/A
Revenue Next Year-5.17%
Revenue Next 2Y-1.07%
Revenue Next 3Y-0.71%
Revenue Next 5YN/A

3.3 Evolution

The estimated forward EPS growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
VRAP.PA Yearly Revenue VS EstimatesVRAP.PA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 100M 200M 300M
VRAP.PA Yearly EPS VS EstimatesVRAP.PA Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 0.5 1

2

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings ratio is 123.50, which means the current valuation is very expensive for VRAP.
Based on the Price/Earnings ratio, VRAP is valued expensively inside the industry as 86.96% of the companies are valued cheaper.
Compared to an average S&P500 Price/Earnings ratio of 27.54, VRAP is valued quite expensively.
Based on the Price/Forward Earnings ratio of 12.17, the valuation of VRAP can be described as correct.
Based on the Price/Forward Earnings ratio, VRAP is valued a bit cheaper than the industry average as 78.26% of the companies are valued more expensively.
VRAP is valuated cheaply when we compare the Price/Forward Earnings ratio to 36.44, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 123.5
Fwd PE 12.17
VRAP.PA Price Earnings VS Forward Price EarningsVRAP.PA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60 80 100

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, VRAP is valued a bit more expensive than 78.26% of the companies in the same industry.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 14.33
VRAP.PA Per share dataVRAP.PA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 10 20 30 40

4.3 Compensation for Growth

VRAP's PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
VRAP's earnings are expected to grow with 18.12% in the coming years. This may justify a more expensive valuation.
PEG (NY)1.47
PEG (5Y)1.92
EPS Next 2Y60.73%
EPS Next 3Y18.12%

5

5. Dividend

5.1 Amount

VRAP has a Yearly Dividend Yield of 6.50%, which is a nice return.
Compared to an average industry Dividend Yield of 2.81, VRAP pays a better dividend. On top of this VRAP pays more dividend than 100.00% of the companies listed in the same industry.
Compared to an average S&P500 Dividend Yield of 2.35, VRAP pays a better dividend.
Industry RankSector Rank
Dividend Yield 6.5%

5.2 History

Dividend Growth(5Y)0%
Div Incr Years0
Div Non Decr Years3
VRAP.PA Yearly Dividends per shareVRAP.PA Yearly Dividends per shareYearly Dividends per share 2019 2022 2023 2024 2025 0.2 0.4 0.6

5.3 Sustainability

VRAP pays out 776.72% of its income as dividend. This is not a sustainable payout ratio.
DP776.72%
EPS Next 2Y60.73%
EPS Next 3Y18.12%
VRAP.PA Yearly Income VS Free CF VS DividendVRAP.PA Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20M 40M
VRAP.PA Dividend Payout.VRAP.PA Dividend Payout, showing the Payout Ratio.VRAP.PA Dividend Payout.PayoutRetained Earnings

VRANKEN - POMMERY MONOPOLE

EPA:VRAP (7/18/2025, 7:00:00 PM)

12.35

+0.05 (+0.41%)

Chartmill FA Rating
GICS SectorConsumer Staples
GICS IndustryGroupFood, Beverage & Tobacco
GICS IndustryBeverages
Earnings (Last)07-17 2025-07-17
Earnings (Next)N/A N/A
Inst Owners0.74%
Inst Owner ChangeN/A
Ins Owners71.03%
Ins Owner ChangeN/A
Market Cap110.41M
Analysts44
Price Target14.03 (13.6%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 6.5%
Yearly Dividend0.8
Dividend Growth(5Y)0%
DP776.72%
Div Incr Years0
Div Non Decr Years3
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)0.65%
Valuation
Industry RankSector Rank
PE 123.5
Fwd PE 12.17
P/S 0.36
P/FCF N/A
P/OCF 6.96
P/B 0.27
P/tB 0.4
EV/EBITDA 14.33
EPS(TTM)0.1
EY0.81%
EPS(NY)1.01
Fwd EY8.22%
FCF(TTM)-0.27
FCFYN/A
OCF(TTM)1.77
OCFY14.37%
SpS34
BVpS44.92
TBVpS31.25
PEG (NY)1.47
PEG (5Y)1.92
Profitability
Industry RankSector Rank
ROA 0.07%
ROE 0.23%
ROCE 3.59%
ROIC 2.04%
ROICexc 2.07%
ROICexgc 2.34%
OM 11.37%
PM (TTM) 0.3%
GM 50.74%
FCFM N/A
ROA(3y)0.44%
ROA(5y)0.39%
ROE(3y)1.41%
ROE(5y)1.26%
ROIC(3y)2.15%
ROIC(5y)1.97%
ROICexc(3y)2.17%
ROICexc(5y)2.01%
ROICexgc(3y)2.46%
ROICexgc(5y)2.31%
ROCE(3y)3.55%
ROCE(5y)3.25%
ROICexcg growth 3Y-6.14%
ROICexcg growth 5Y11.64%
ROICexc growth 3Y-4.42%
ROICexc growth 5Y11.55%
OM growth 3Y6.3%
OM growth 5Y8.09%
PM growth 3Y-50.55%
PM growth 5Y61.17%
GM growth 3Y3.29%
GM growth 5Y-0.37%
F-Score5
Asset Turnover0.23
Health
Industry RankSector Rank
Debt/Equity 1.5
Debt/FCF N/A
Debt/EBITDA 12.39
Cap/Depr 130.49%
Cap/Sales 6%
Interest Coverage 250
Cash Conversion 32.69%
Profit Quality N/A
Current Ratio 2.02
Quick Ratio 0.27
Altman-Z 0.85
F-Score5
WACC4.58%
ROIC/WACC0.45
Cap/Depr(3y)114.75%
Cap/Depr(5y)104.39%
Cap/Sales(3y)5.1%
Cap/Sales(5y)5.18%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-85.12%
EPS 3Y-50.41%
EPS 5Y64.31%
EPS Q2Q%-65.69%
EPS Next Y84.26%
EPS Next 2Y60.73%
EPS Next 3Y18.12%
EPS Next 5YN/A
Revenue 1Y (TTM)-10.16%
Revenue growth 3Y0.3%
Revenue growth 5Y2.05%
Sales Q2Q%-11.88%
Revenue Next Year-5.17%
Revenue Next 2Y-1.07%
Revenue Next 3Y-0.71%
Revenue Next 5YN/A
EBIT growth 1Y-11.37%
EBIT growth 3Y6.63%
EBIT growth 5Y10.31%
EBIT Next Year34.21%
EBIT Next 3Y13.12%
EBIT Next 5YN/A
FCF growth 1Y-108.55%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-66.14%
OCF growth 3Y-37.15%
OCF growth 5Y55.04%